Maurizio Memo
#163,003
Most Influential Person Now
Researcher
Maurizio Memo's AcademicInfluence.com Rankings
Maurizio Memocomputer-science Degrees
Computer Science
#9529
World Rank
#10003
Historical Rank
Machine Learning
#4195
World Rank
#4244
Historical Rank
Artificial Intelligence
#4542
World Rank
#4604
Historical Rank
Database
#6494
World Rank
#6728
Historical Rank
Download Badge
Computer Science
Maurizio Memo's Degrees
- PhD Computer Science University of Milan
- Masters Artificial Intelligence University of Bologna
- Bachelors Computer Engineering University of Florence
Similar Degrees You Can Earn
Why Is Maurizio Memo Influential?
(Suggest an Edit or Addition)Maurizio Memo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation (1996) (790)
- Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease (2012) (525)
- Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. (2018) (297)
- Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? (2001) (230)
- Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis (2009) (177)
- Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction (1999) (177)
- Interleukin-1β and Glutamate Activate the NF-κB/Rel Binding Site from the Regulatory Region of the Amyloid Precursor Protein Gene in Primary Neuronal Cultures* (1996) (147)
- Zebrafish Larvae as a Behavioral Model in Neuropharmacology (2019) (144)
- Impaired Adult Neurogenesis Associated with Short-Term Memory Defects in NF-κB p50-Deficient Mice (2008) (137)
- Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. (2012) (120)
- Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway (1999) (119)
- Attenuation of Excitatory Amino Acid Toxicity by Metabotropic Glutamate Receptor Agonists and Aniracetam in Primary Cultures of Cerebellar Granule Cells (1993) (116)
- Metabotropic glutamate receptor mRNA expression in rat spinal cord (1997) (110)
- Identification and Characterization of a κB/Rel Binding Site in the Regulatory Region of the Amyloid Precursor Protein Gene (*) (1995) (107)
- Induction of tumour‐suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids (1998) (105)
- Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE,in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease (2008) (103)
- Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. (1983) (103)
- The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death (2004) (99)
- Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease (2008) (96)
- Aging process affects a single class of dopamine receptors (1980) (91)
- Impairment of brain neurotransmitter receptors in aged rats (1980) (91)
- p53 at the crossroads between cancer and neurodegeneration. (2012) (88)
- Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity (2003) (87)
- Distinct Developmental Patterns of Expression of Rat α1, α5, γ2S, andα12Lγ‐Aminobutyric AcidA Receptor Subunit mRNAs In Vivo and In Vitro (1992) (86)
- mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study (1997) (85)
- Conformationally altered p53: a novel Alzheimer's disease marker? (2008) (85)
- Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment. (2019) (82)
- D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP (1986) (77)
- Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. (2002) (75)
- Dopamine D2, D3, and D4 receptor mRNA levels in rat brain and pituitary during aging (1994) (73)
- Nutrition and AGE-ing: Focusing on Alzheimer's Disease (2017) (73)
- Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors. (1991) (72)
- Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. (2008) (72)
- Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer’s Disease Brain: Implications for AD Pathogenesis (2009) (72)
- Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53 (2009) (71)
- Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas. (1979) (71)
- Cannabimimetic plants: are they new cannabinoidergic modulators? (2019) (68)
- Activation of Multiple Metabotropic Glutamate Receptor Subtypes Prevents NMDA‐induced Excitotoxicity in Rat Hippocampal Slices (1996) (68)
- Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease (2012) (68)
- Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum. (1982) (68)
- Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin (1981) (67)
- Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. (1999) (65)
- GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. (2014) (63)
- Dopaminergic Inhibition of Prolactin Release and Calcium Influx Induced by Neurotensin in Anterior Pituitary Is Independent of Cyclic AMP System (1986) (63)
- Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs. (1989) (62)
- Identification of β‐Adrenergic Receptor Binding Sites in Rat Brain Micro vessels, Using [125I]Iodohydroxybenzylpindolol (1981) (61)
- Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding (1989) (61)
- Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole (2010) (61)
- Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients (2006) (61)
- Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line. (1991) (60)
- Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. (1996) (56)
- Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? (1996) (56)
- Unfolded p53: a potential biomarker for Alzheimer's disease. (2007) (55)
- Physiological levels of amyloid peptides stimulate the angiogenic response through FGF‐2 (2004) (53)
- Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line (1997) (53)
- Homeodomain Interacting Protein Kinase 2: A Target for Alzheimer's Beta Amyloid Leading to Misfolded p53 and Inappropriate Cell Survival (2010) (50)
- Using iPS Cells toward the Understanding of Parkinson’s Disease (2015) (50)
- Hearing loss and cognitive decline in older adults: questions and answers (2014) (49)
- Brain neurotransmitter system and chronic lead intoxication. (1980) (49)
- TorsinA negatively controls neurite outgrowth of SH-SY5Y human neuronal cell line (2004) (49)
- TRAIL is expressed in the brain cells of Alzheimer's disease patients (2004) (49)
- Identification and characterization of postsynaptic D1- and D2-dopamine receptors in the cardiovascular system. (1988) (49)
- Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells. (2010) (48)
- Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients (2016) (47)
- Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity (1996) (47)
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference (2015) (47)
- Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study (2018) (46)
- Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices (1988) (46)
- Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. (1991) (46)
- Alzheimer's disease linking neurodegeneration with neurodevelopment. (2003) (45)
- Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells (1985) (45)
- Peripheral and central mechanisms of action of serotoninergic anorectic drugs (1986) (45)
- Brain benzodiazepine receptor changes during ageing (1981) (45)
- Nuclear Factor κB-Dependent Neurite Remodeling Is Mediated by Notch Pathway (2011) (45)
- Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol (1987) (45)
- Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa. (1986) (45)
- Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2). (2002) (44)
- gamma-Aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands. (1991) (44)
- Chronic lead treatment induces in rat a specific and differential effect on dopamine receptors in different brain areas (1981) (42)
- Phytochemical Analysis and Anti-Inflammatory Activity of Different Ethanolic Phyto-Extracts of Artemisia annua L. (2021) (42)
- Identification of Neurotensin Receptors Associated with Calcium Channels and Prolactin Release in Rat Pituitary (1986) (41)
- p53 is dispensable for apoptosis but controls neurogenesis of mouse dentate gyrus cells following gamma-irradiation. (2001) (41)
- Protective Effects of Gynostemma pentaphyllum (var. Ginpent) against Lipopolysaccharide-Induced Inflammation and Motor Alteration in Mice (2021) (40)
- Sulphurous Thermal Water Increases the Release of the Anti-Inflammatory Cytokine IL-10 and Modulates Antioxidant Enzyme Activity (2013) (40)
- Dopaminergic Receptor Mechanisms Modulating the Renin‐Angiotensin System and Aldosterone Secretion: An Overview (1989) (40)
- Gamma-oryzanol Prevents LPS-induced Brain Inflammation and Cognitive Impairment in Adult Mice (2019) (40)
- Clinical potentials of human pluripotent stem cells (2017) (40)
- Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions. (1987) (39)
- Blockade of the Tumor Necrosis Factor-Related Apoptosis Inducing Ligand Death Receptor DR5 Prevents β-Amyloid Neurotoxicity (2007) (39)
- Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane (2010) (39)
- Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes. (2015) (38)
- Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically. (2000) (38)
- Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation (2018) (38)
- Reversal of glutamate excitotoxicity by activation of PKC‐associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression (1999) (37)
- High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma (2017) (36)
- Dose-dependent and reversible effects of lead on rat dopaminergic system. (1981) (34)
- Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes (2019) (34)
- Involvement of DNA damage and repair systems in neurodegenerative process. (2003) (34)
- Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex. (1988) (34)
- Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish (2016) (34)
- Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action (2020) (33)
- Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients. (2016) (33)
- Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways (2009) (33)
- Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions (2004) (32)
- Dietary zeolite supplementation reduces oxidative damage and plaque generation in the brain of an Alzheimer's disease mouse model. (2013) (31)
- The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines (2016) (31)
- Zebrafish Embryo as an In Vivo Model for Behavioral and Pharmacological Characterization of Methylxanthine Drugs (2017) (31)
- Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression (2013) (31)
- Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease Patients (2010) (31)
- Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice (2016) (31)
- Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease (2008) (31)
- Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus (1988) (30)
- Contribution of NF-κB and p53 in the glutamate-induced apoptosis (2000) (30)
- Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. (1999) (30)
- Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area (1986) (29)
- Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries (1985) (29)
- Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. (2010) (28)
- Distribution and kainate-mediated induction of the DNA mismatch repair protein MSH2 in rat brain (1999) (28)
- Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. (1988) (27)
- Notch signalling in adult neurons: a potential target for microtubule stabilization (2013) (27)
- Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue. (1986) (27)
- Effect of chronic lead treatment on GABA-ergic receptor function in rat brain. (1980) (27)
- “RaMassays”: Synergistic Enhancement of Plasmon-Free Raman Scattering and Mass Spectrometry for Multimodal Analysis of Small Molecules (2016) (27)
- An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin (2015) (27)
- A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation. (2004) (27)
- Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders (2017) (27)
- Alzheimer's disease: new diagnostic and therapeutic tools (2008) (26)
- Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. (2016) (26)
- Behavioral abnormalities in the Fmr1‐KO2 mouse model of fragile X syndrome: The relevance of early life phases (2017) (25)
- Induction of Two DNA Mismatch Repair Proteins, MSH2 and MSH6, in Differentiated Human Neuroblastoma SH‐SY5Y Cells (1999) (25)
- The role of chirality in a set of key intermediates of pharmaceutical interest, 3‐aryl‐substituted‐&ggr;‐butyrolactones, evidenced by chiral HPLC separation and by chiroptical spectroscopies (2017) (25)
- Mitochondria and cellular redox state on the route from ageing to Alzheimer’s disease (2020) (24)
- Characterization of the Antioxidant Effects of γ-Oryzanol: Involvement of the Nrf2 Pathway (2018) (24)
- Importance and Difficulties in the Use of Chiroptical Methods to Assign the Absolute Configuration of Natural Products: The Case of Phytotoxic Pyrones and Furanones Produced by Diplodia corticola. (2017) (24)
- Monitoring Caco-2 to enterocyte-like cells differentiation by means of electric impedance analysis on printed sensors. (2019) (23)
- Detection of multiple receptors for dopamine. (1980) (23)
- Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex. (1985) (23)
- Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy (2015) (23)
- Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein–Protein Docking, Molecular Dynamics, and MM-GBSA Calculations (2021) (23)
- DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration (2019) (23)
- Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist (2020) (23)
- Notch activation induces neurite remodeling and functional modifications in SH‐SY5Y neuronal cells (2009) (22)
- Stimulation of dopamine D-2 receptors increases potassium permeability in mammotrophs. (1987) (22)
- Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis. (1992) (22)
- Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult. (1999) (21)
- Characterization of dopamine receptors in various species of invertebrates and vertebrates (1981) (21)
- Inhibition of Glutamate‐induced Neurotoxicity by a Tau Antisense Oligonucleotide in Primary Culture of Rat Cerebellar Granule Cells (1995) (21)
- Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity? (1997) (20)
- Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells. (2016) (20)
- A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) (2020) (20)
- Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53. (2008) (20)
- γ-Oryzanol Improves Cognitive Function and Modulates Hippocampal Proteome in Mice (2019) (19)
- Antisense Strategy Unravels a Dopamine Receptor Distinct from the D2 Subtype, Uncoupled with Adenylyl Cyclase, Inhibiting Prolactin Release from Rat Pituitary Cells (1994) (19)
- Ferrous Iron Up-regulation in Fibroblasts of Patients with Beta Propeller Protein-Associated Neurodegeneration (BPAN) (2017) (19)
- A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. (1993) (19)
- Palbociclib inhibits proliferation of human adrenocortical tumor cells (2017) (18)
- Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex (1988) (18)
- Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways (2010) (18)
- Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens (1986) (18)
- Zyxin is a novel target for beta‐amyloid peptide: characterization of its role in Alzheimer's pathogenesis (2013) (18)
- Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection (2018) (18)
- Nerve growth factor restores p53 function in pituitary tumor cell lines via trkA-mediated activation of phosphatidylinositol 3-kinase. (2004) (18)
- Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics (1981) (18)
- Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma (2017) (18)
- Preservation of DNA integrity and neuronal degeneration (2005) (18)
- Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. (1995) (17)
- Inhibition of Aldosterone Secretion by Dopamine, Ibopamine, and Dihydroergotoxine in Patients with Congestive Heart Failure (1989) (17)
- Dopamine receptor agonists for protection and repair in Parkinson's disease. (2008) (17)
- Rat pituitary cells selectively express mRNA encoding the short isoform of the y2 GABAA receptor subunit. (1992) (17)
- Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway (2018) (16)
- Wireless Point-of-Care Platform With Screen-Printed Sensors for Biomarkers Detection (2017) (16)
- Lack of correlation between the neurochemical and behavioural effects induced by d-amphetamine in chronically lead-treated rats (1980) (16)
- A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages (2020) (16)
- Interaction of dopaminergic ergot derivatives with cyclic nucleotide system. (1980) (16)
- Opposing regulation of tau protein levels by ionotropic and metabotropic glutamate receptors in human NT2 neurons (1998) (15)
- Critical Review on the Chemical Aspects of Cannabidiol (CBD) and Harmonization of Computational Bioactivity Data. (2020) (15)
- Induction of p53 in the glutamate-induced cell death program (2000) (15)
- In vitro antitumor activity of progesterone in human adrenocortical carcinoma (2018) (15)
- Activation of Dopamine D2 Receptors Linked to Voltage‐Sensitive Potassium Channels Reduces Forskolin‐Induced Cyclic AMP Formation in Rat Pituitary Cells (1992) (15)
- The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease (2020) (15)
- Identification of D-2 dopaminergic receptors in bovine adrenal cortex. (1985) (15)
- Redox Homeostasis and Natural Dietary Compounds: Focusing on Antioxidants of Rice (Oryza sativa L.) (2018) (15)
- Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD) (2021) (15)
- Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. (1995) (15)
- Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS. (1983) (14)
- Advances in Alzheimer’s and Parkinson’s Disease (2008) (14)
- Long‐lasting induction of Notch2 in the hippocampus of kainate‐treated adult mice (2003) (14)
- The differences in the pharmacological profiles of various benzodiazepine recognition site ligands may be associated with GABAA receptor structural diversity. (1990) (14)
- Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride (1982) (14)
- Specific profile of ultrasonic communication in a mouse model of neurodevelopmental disorders (2019) (13)
- Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptors. (1985) (13)
- Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos (2017) (13)
- Distinct developmental patterns of expression of rat alpha 1, alpha 5, gamma 2S, and gamma 2L gamma-aminobutyric acidA receptor subunit mRNAs in vivo and in vitro. (1992) (13)
- Striatal adenylate cyclase-inhibiting dopamine D2 receptors are not affected by the aging process (1987) (13)
- Pramipexole prevents neurotoxicity induced by oligomers of beta-amyloid. (2007) (13)
- Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical Spectroscopy. (2016) (13)
- Biosimilars: Regulatory Status and Implications across the World (2016) (12)
- Advanced Glycation End Products (Ages) in Food: Focusing on Mediterranean Pasta (2015) (12)
- Priming of cultured neurons with sabeluzole results in long‐lasting inhibition of neurotoxin‐induced tau expression and cell death (1997) (12)
- Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells (2020) (12)
- Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? (2014) (12)
- Wild type but not mutant APP is involved in protective adaptive responses against oxidants (2010) (12)
- Repeated administration of lisuride down-regulates dopamine D-2 receptor function in mesostriatal and in mesolimbocortical rat brain regions. (1990) (12)
- Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach (2019) (12)
- Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity (2017) (11)
- Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises. (2013) (11)
- Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report (2016) (11)
- Effect of temperature and ionic environment on the specific binding of 3H(—)sulpiride to membranes from different rat brain regions (1985) (11)
- Evidence on selective binding to G-quadruplex DNA of isoflavones from Maclura pomifera by mass spectrometry and molecular docking (2019) (11)
- Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. (1990) (10)
- Characterization of monoaminergic receptors in hypothalamic nuclei mediating feeding behavior in rats. (1991) (10)
- Ultrasonic vocalizations in mice: relevance for ethologic and neurodevelopmental disorders studies (2020) (10)
- A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2) (2021) (10)
- Phosphorylation of membrane proteins in response to persistent stimulation of adenylate cyclsae-linked dopamine receptors in slices of striatum (1984) (10)
- α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate differently affect neuronal cytoarchitecture of rat cerebellar granule cells (1994) (10)
- Properties of benzodiazepine binding sites in peripheral blood lymphocytes (1989) (10)
- TorsinA, microtubules and cell polarity. (2003) (10)
- Requirement of oestrogens for the sensitivity of prolactin cells to vasoactive intestinal peptide in rats and man. (1992) (10)
- Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors. (1980) (9)
- Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers (2017) (9)
- Automatic classification of mice vocalizations using Machine Learning techniques and Convolutional Neural Networks (2021) (9)
- In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ (2019) (9)
- Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice. (2021) (9)
- Mitochondrial dysfunction and increased sensitivity to excitotoxicity in mice deficient in DNA mismatch repair (2006) (9)
- Investigation of the molecular reactivity of bioactive oxiranylmethyloxy anthraquinones (2019) (8)
- Contribution of NF-kappaB and p53 in the glutamate-induced apoptosis. (2000) (8)
- Interleukin-1b and Glutamate Activate the NF-kB/Rel Binding Site from the Regulatory Region of the Amyloid Precursor Protein Gene in Primary Neuronal Cultures* (1996) (8)
- A Perspective on Natural and Nature-Inspired Small Molecules Targeting Phosphodiesterase 9 (PDE9): Chances and Challenges against Neurodegeneration (2021) (8)
- Expression of cell-cycle-related proteins and excitoxicity (2002) (8)
- Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model. (2015) (8)
- Synthesis via A3 Coupling Reaction of Anthracene‐Propargylamine as a New Scaffold for the Interaction with DNA (2019) (8)
- Vasoactive intestinal polypeptide (VIP) selectively stimulates prolactin release in healthy women. (1988) (7)
- Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate. (2019) (7)
- Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice. (2021) (7)
- Differential effect of acute reserpine administration on D-1 and D-2 dopaminergic receptor density and function in rat striatum (1989) (7)
- Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins? (2021) (7)
- Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations (1989) (7)
- Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer (2021) (7)
- Multi-target Natural and Nature-Inspired Compounds against Neurodegeneration: A Focus on Dual Cholinesterase and Phosphodiesterase Inhibitors (2021) (7)
- Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS. (1980) (6)
- A new educational program in heart failure drug development: the Brescia international master program (2018) (6)
- Cytoskeletal Protection: Acting on Notch to Prevent Neuronal Dysfunction (2013) (6)
- A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. (1990) (6)
- Favorable prognostic role of tropomodulins in neuroblastoma (2018) (6)
- Amyloid Precursor Protein (APP) Gene Expression is Controlled by a NFkB/Rel Related Protein (1995) (6)
- Enhanced Sensing of Interleukin 8 by Stripping Voltammetry: Carbon Nanotubes versus Fullerene (2017) (6)
- Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines (2019) (5)
- 2-(3,4-Dihydroxyphenyl)-4-(2-(4-nitrophenyl)hydrazono)-4H-chromene-3,5,7-triol (2020) (5)
- Caffeine Inhibits Direct and Indirect Angiogenesis in Zebrafish Embryos (2021) (5)
- Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells. (2021) (5)
- N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. (1995) (5)
- Vasoactive intestinal polypeptide loses its prolactin-releasing activity in menopausal women. (1989) (5)
- Brain Structural and Functional Alterations in Mice Prenatally Exposed to LPS Are Only Partially Rescued by Anti-Inflammatory Treatment (2020) (5)
- Erratum: Glutathionylation of the pro-apoptotic protein p53 in alzheimer's disease brain: Implications for AD pathogenesis (Neurochemical Research (2009) 34 (727-733) DOI 10.1007/s11064-009-9924-9 (2009) (4)
- Design of compositive on-line monitoring and fault diagnosis system for high-voltage switch cabinet (2011) (4)
- Enhanced G-quadruplex selectivity of flavonoid glycoside rutin over quercetin (2020) (4)
- Photoactivated semi-synthetic derivative of osajin selectively interacts with G-quadruplex DNA (2020) (4)
- Dopaminergic Agonists: Possible Neurorescue Drugs Endowed with Independent and Synergistic Multisites of Action (2007) (4)
- Different Seasonal Collections of Ficus carica L. Leaves Diversely Modulate Lipid Metabolism and Adipogenesis in 3T3-L1 Adipocytes (2022) (4)
- DNA damage and DNA repair in the nervous system. (1999) (4)
- Chronic lead exposure alters dopaminergic mechanisms in rat pituitary. (1986) (4)
- Dementia with Lewy Bodies: Cholinergic therapy and Lewy body dementia (1996) (3)
- Characterization and localization of dopamine-D2 central receptors (1981) (3)
- Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives (2004) (3)
- COVID-19 Aftermath: Exploring the Mental Health Emergency among Students at a Northern Italian University (2022) (3)
- Dopaminergic System in the Aged Brain: Evidence for a Selective Loss of D-1 But Not D-2 Receptors (1987) (3)
- Exploring SARS-CoV-2 Delta variant spike protein receptor-binding domain (RBD) as a target for tanshinones and antimalarials (2022) (3)
- Biochemical Pharmacology of Dopamine Receptors (1984) (3)
- Virtual Screening and In Vitro Experiments Highlight Cannabidiol as a Drug-like Phosphodiesterase 9 Inhibitor. (2022) (3)
- mGluR5 immunolocalization in foetal and adult human spinal cord (1996) (3)
- Deafferentation induces early and delayed differential changes in the pattern of expression of the various guanine nucleotide binding protein mRNAs in rat striatum (1993) (3)
- Combinatorial library generation, molecular docking and molecular dynamics simulations for enhancing the isoflavone scaffold in phosphodiesterase inhibition (2020) (3)
- Conformational altered p 53 as an early marker of oxidative stress in Alzheimer ' s disease (2017) (3)
- Differential affinity of dopaminergic agonists and antagonists for D1 and D2 dopamine receptors in rat striatum. (1983) (3)
- Maternal immune activation and abnormal brain development: new insights on neurodevelopmental disorders pathogenesis (2017) (3)
- Molecular mechanisms of glutamate-induced neurodegeneration (1995) (2)
- DOPAMINE RECEPTORS AND SECOND MESSENGERS (1984) (2)
- Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease. (2005) (2)
- Conformationally altered p53: A potential predictive marker from mild cognitive impairment to Alzheimer's disease? (2009) (2)
- Expression of (gamma-amino butyric acid)A receptor subunit mRNAs in neurons differentiating in culture (1991) (2)
- Implication of dopamine receptor diversity in the mechanism of action of antipsychotic drugs (1992) (2)
- Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors (2004) (2)
- Evidence for the existence of two distinct dopamine D-2 receptors in presynaptic nerve terminals from rat corpus striatum (1993) (2)
- Cellular mechanisms for neurotensin receptor-mediated release of prolactin. (1985) (2)
- Pharmacological basis for dopamine D-2 receptor diversity (1992) (2)
- Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib. (2021) (2)
- Role of calmodulin in the regulation of dopamine receptor function. (1984) (2)
- Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients (2016) (2)
- Localization of GABA and dopamine receptor sites in retinal glial cells using DL-alpha-aminoadipic acid. (1981) (2)
- Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs (2019) (2)
- Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models. (2022) (2)
- Combining Electrospray Mass Spectrometry (ESI-MS) and Computational Techniques in the Assessment of G-Quadruplex Ligands: A Hybrid Approach to Optimize Hit Discovery (2021) (2)
- Combining computational and experimental evidence on the activity of antimalarial drugs on papain‐like protease of SARS‐CoV‐2: A repurposing study (2022) (2)
- Role of melatonin in autism spectrum disorders in a male murine transgenic model: Study in the prefrontal cortex (2021) (2)
- Selective expression of the mRNA encoding the short isoform of the gamma 2 GABA-A receptor subunit in rat pituitary cells. (1992) (2)
- Biochemical aspects in striatal dopamine receptor desensitization (1983) (1)
- Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats. (1992) (1)
- Dopamine D-2 Receptor Agonists Decrease the Basal Level of Inositol 1,4,5-Trisphosphate in Rat Striatal Slices (1988) (1)
- Fibroblasts from sporadic alzheimer's disease patients respond abnormally to hydrogen peroxide (2001) (1)
- Effect of temperature and ionic environment on the specific binding of (3)H(-)sulpiride to membranes from different rat brain regions. (1985) (1)
- Intracellular Pathways Involved in DNA Damage and Repair to Neuronal Apoptosis (2006) (1)
- Impact of COVID-19-Related Social Isolation on Behavioral Outcomes in Young Adults Residing in Northern Italy (2022) (1)
- THE DIFFERENTIAL COUPLING MECHANISM OF DOPAMINE D‐2 RECEPTOR SUBTYPES: IMPORTANCE FOR THE ACTIONS OF NEUROLEPTIC DRUGS. (1992) (1)
- Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer’s Disease Brain: Implications for AD Pathogenesis (2009) (1)
- Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease. (2002) (1)
- Unfolded P53 as a novel lead biomarker for Alzheimer’s disease diagnosis (2020) (1)
- Pharmacological and molecular basis for dopamine D-2 receptor diversity (1990) (1)
- Functional changes of striatal D-1 receptor subunits after repeated reserpine treatment (1988) (1)
- ’ s disease linking neurodegeneration with neurodevelopment (1)
- The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology (2023) (1)
- Sulpiride and Other Benzamides as Specific Antagonists at the D2 Dopamine Receptor (1981) (1)
- Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study (2022) (1)
- Differential up‐regulation of D‐1 and D‐2 dopamine receptor function in mesostriatal areas but not in cortical‐limbic brain regions of rats chronically treated with (—)sulpiride and SCH 23390 (1987) (1)
- Multiple Transduction Mechanisms for Dopamine D2 Receptors in Anterior Pituitary Cells (1987) (1)
- Subclinical thyrotoxicosis and bone (2018) (1)
- 9th IFAC International Symposium on Advanced Control of Chemical Processes (ADCHEM 2015) : Whistler, Canada 7-10 June 2015 (2016) (1)
- Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration (1994) (1)
- Long-term behavioral effects of prenatal stress in the Fmr1-knock-out mouse model for fragile X syndrome (2022) (1)
- Amiloride effects on abiraterone antiproliferative activity in prostate cancer cells in vitro and on clinical management of abiraterone induced mineralocorticoid excess syndrome. (2016) (1)
- Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus. (1989) (1)
- Carbon on poly(ε-caprolactone) (PCL) Ink-jet Printed Sensor for Monitoring Cell Cultures of Myoblasts (2017) (1)
- Neuronal networks in emotions. (2002) (1)
- H -chromene-3,5,7-triol (2020) (1)
- Industrialists set up first school of molecular medicine (1995) (0)
- Dopamine D-2 receptors modulate aldosterone secretion (1987) (0)
- In vitro and in vivo evaluation of cytotoxic effect of targeted agents alone or in combination with chemotherapy for the treatment of adenoid cystic carcinoma (2021) (0)
- Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. (1988) (0)
- Inhibition of Excitatory Amino Acid-Induced Neurotoxicity by a Tau Antisense Oligonucleotide in Primary Culture of Cerebellar Granule Cells (1995) (0)
- Conformationally altered p53 as a peripheral marker for mild Alzheimer's disease (2010) (0)
- NOTCH AND NF-ΚB PATHWAY CROSS-TALK REGULATES NEURITE REMODELLING (2011) (0)
- Benzodiazepine sensitivity and structure of gaba a receptor subtypes (1989) (0)
- Calmodulin and Dopamine Receptor Regulation (1982) (0)
- FROM BLOOD-BASED REDOX PROFILE TO THE IDENTIFICATION OF A LEAD BIOMARKER FOR THE TIMELY DIAGNOSIS OF ALZHEIMER’S DISEASE (2018) (0)
- Calcium and cyclic AMP-independent release of PRL induced by VIP (1988) (0)
- Comprar Advances in Alzheimers and Parkinsons Disease · Insights, Progress, and Perspectives | Fisher, Abraham | 9780387720746 | Springer (2008) (0)
- Evidence for a functional interaction between potassium channels and dopamine receptors in rat lactotrophs (1988) (0)
- Impaired DNA Repair Systems: Generation of Mitochondrial Dysfunction and Increased Sensitivity to Excitotoxicity (2008) (0)
- Conformationally altered p53: a potential predictive marker from mci to alzheimer’s disease? (2009) (0)
- Dopamine receptors are present in rat and human esophagus (1988) (0)
- Effects of naloxone in patients with bronchial asthma and chronic obstructive pulmonary disease (1988) (0)
- S-8-4 Functional and pharmacological distinctions between subtypes of dopamine D-2 receptors (1995) (0)
- Effect of ace-inhibitor enalapril on plasma levels in human hypertensives (1988) (0)
- Inverse Poly-High Internal Phase Emulsions Poly(HIPEs) Materials from Natural and Biocompatible Polysaccharides (2020) (0)
- Transduction Mechanisms at Dopamine Receptors (1986) (0)
- Homeodomain interacting protein kinase 2 as a target of beta amyloid leads to altered p53 folding and functions. (2010) (0)
- Pharmacological and functional basis of dopamine D-2 receptor diversity (1990) (0)
- Stimulation of D-2 dopamine receptors inhibits the aldosterone response to sodium depletion in hypertensive patients (1988) (0)
- Conference (1999) (0)
- Amino‐Acid‐Anthraquinone Click Chemistry Conjugates Selectively Target Human Telomeric G‐Quadruplexes (2021) (0)
- IRC WORKSHOP ON PROCESS SYSTEMS ENGINEERING AND CONTROL Date : Thursday , Feb 25 , 2016 Time : 8 : 00 AM – 3 : 00 PM Venue : ETLC Solarium (2016) (0)
- Compensatory Mechanisms At Dopamine D-2 Receptors (1994) (0)
- Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos (2017) (0)
- [Regulation mechanisms in prolactin secretion. Possible role of the hypophyseal renin-angiotensin system]. (1990) (0)
- Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines (2019) (0)
- International Symposium on Advanced Control of Industrial Processes [Conference Reports] (2017) (0)
- A l z h e i m e r's disease linking neurodegeneration with neurodevelopment (2003) (0)
- Pro-Angiogenetic Effects of Purified Extracts from Helix aspersa during Zebrafish Development (2022) (0)
- An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin (2015) (0)
- Greetings from the IPC and NOC chairs (2011) (0)
- VALIDATION OF A NEW ANTIBODY THAT RECOGNIZES A CONFORMATIONAL VARIANT OF P53 SPECIFIC FOR ALZHEIMER’S AT THE PRE-CLINICAL AND PRODROMAL STAGES OF THE DISEASE (2019) (0)
- Conformational mutant p53 isoform: a novel alzheimer’s disease marker? (2007) (0)
- Evidence for multiple transduction mechanisms of dopamine D-2 receptors (1987) (0)
- The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease (2020) (0)
- Functional neurology at the dawn of the third millennium: the translation of neuroscience into neurology. (2002) (0)
- Scientific Summaries for Families with ASD (2017) (0)
- Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. (1992) (0)
- Cannabimimetic plants: are they new cannabinoidergic modulators? (2019) (0)
- High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy (2017) (0)
- From blood-based redox profile to the validation of a lead biomarker for the timely diagnosis of Alzheimer’s disease (2017) (0)
- Lead effects on rat dopaminergic system (1980) (0)
- The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines (2016) (0)
- Tolerance to hypoactivity and sensitization to hyperactivity following chronic treatment with á presynaptic dose of lisuride in rats (1992) (0)
- Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments. (1994) (0)
- NEUROPROTECTIVE EFFECTS OF ANIRACETAM (1992) (0)
- AN OPEN ISOFORM OF P53 AS AN EARLY BIOMARKER OF BLOOD REDOX ALTERATIONS IN ALZHEIMER’S DISEASE: DEVELOPMENT OF AN EASY AND REPRODUCIBLE ASSAY (2016) (0)
- Medical-health recommendations for the Serie A League (2021) (0)
- PERIPHERAL MITOCHONDRIAL DYNAMICS IN ALZHEIMER'S DISEASE (2014) (0)
- Molecular Characterization of the Neuroprotective Activity of Salicylates (1998) (0)
- Dopamine D2 receptors modulate neurotransmitter-regulated calcium ion gates. (1984) (0)
- 9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop-2-yne-1-yl]anthracene: Synthesis and G-quadruplex Selectivity (2020) (0)
- INHIBITS PROLIFERATION OF HUMAN ADRENOCORTICAL TUMOR CELLS (0)
- alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate differently affect neuronal cytoarchitecture of rat cerebellar granule cells. (1994) (0)
- Synapsin III Controls Early Phases of Dopaminergic Neurons Development in Fishes and Mammals by Acting Upstream of BDNF and Cdk5 Signaling (2021) (0)
- A superfusion method for the study of calcium fluxes from pituitary cells. (1988) (0)
- A NOVEL DOPAMINE RECEPTOR SUBTYPE IN BROWN ADIPOSE TISSUE (1992) (0)
- Supplementary Material for: Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity (2017) (0)
- Common Mechanisms in Cell Cycle and Cell Death (1998) (0)
- Clinical potentials of human pluripotent stem cells (2017) (0)
- Dopamine-gated potassium channels (1992) (0)
- New frontiers in molecular oncology: From oncogenes to novel challenges in cancer therapy (1995) (0)
- Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates (2022) (0)
- P4-175: Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer's disease (2008) (0)
- 7th International Conference AD/PD 2005, Sorrento, Italy, March 9–14, 2005 (2006) (0)
- A BLOOD-BASED REDOX PROFILE AS A FINGERPRINT FOR ALZHEIMER PATHOLOGY (2017) (0)
- Neurotransmitters and cotransmitters in receptor function (1983) (0)
- Various calcium entry blokers prevent glutamate-induced neurotoxicity (1992) (0)
- Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy (2014) (0)
- Welcome to the New Open Access NeuroSci (2020) (0)
- [Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. (1987) (0)
- Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines (2023) (0)
- A NEW PUTATIVE EARLY BIOMARKER FOR A BLOOD-BASED TIMELY DIAGNOSIS FOR ALZHEIMER’S DISEASE (2017) (0)
- Intracellular Ionic Changes Induced by Dopamine Receptor Stimulation in Mammotrophs: Evidence for a K+ Channel-linked Dopamine D-2 Receptor (1988) (0)
- Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach (2015) (0)
- [Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Maurizio Memo?
Maurizio Memo is affiliated with the following schools:
